SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031916
Filing Date
2024-08-14
Accepted
2024-08-14 09:00:26
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 914084
2 ex31-1.htm EX-31.1 19957
3 ex31-2.htm EX-31.2 19969
4 ex32-1.htm EX-32.1 8231
  Complete submission text file 0001493152-24-031916.txt   4585143

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE imnn-20240630.xsd EX-101.SCH 34350
6 XBRL CALCULATION FILE imnn-20240630_cal.xml EX-101.CAL 48789
7 XBRL DEFINITION FILE imnn-20240630_def.xml EX-101.DEF 146380
8 XBRL LABEL FILE imnn-20240630_lab.xml EX-101.LAB 339804
9 XBRL PRESENTATION FILE imnn-20240630_pre.xml EX-101.PRE 273307
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 543126
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 241204478
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)